SCHEMBL30774398

SCHEMBL30774398

N#Cc1ccc(-c2cncc3c2OCCN3C(=O)[C@H]2CCN(Cc3cccc(F)c3)C2)cc1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ USP30 Q70CQ3 3/20 0.46
▸ ALDH1A1 P00352 2/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ HPGD P15428 1/20 0.42
▸ CCR3 P51677 1/20 0.40
▸ FAAH O00519 1/20 0.39
▸ UCHL1 P09936 1/20 0.39
▸ PDCD1 Q15116 2/20 0.38
▸ CD274 Q9NZQ7 2/20 0.38
▸ HTT P42858 1/20 0.38
▸ MLNR O43193 1/20 0.38
▸ POLB P06746 1/20 0.37
▸ ADRB2 P07550 1/20 0.37
▸ ACHE P22303 1/20 0.37
▸ KDM1A O60341 1/20 0.37
▸ MEN1 O00255 1/20 0.36
▸ KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30774644 1.00 USP30 (0.46) USP30ALDH1A1KDM4EHPGDCCR3
SCHEMBL30774590 0.95 USP30 (0.42) USP30ALDH1A1KDM4EHPGDUCHL1
SCHEMBL30774840 0.87 ROCK2 (0.44) USP30FAAHUCHL1PDCD1CD274
SCHEMBL30774832 0.85 PRKAA2 (0.41) USP30
SCHEMBL30774354 0.84 USP30 (0.43) USP30FAAHUCHL1MLNRKDM1A
SCHEMBL30774900 0.83 TNIK (0.42) USP30ALDH1A1KDM4EHPGDPDCD1
SCHEMBL31635551 0.83 ALDH1A1 (0.48) ALDH1A1KDM4EHPGDCCR3FAAH
SCHEMBL30773988 0.83 NAAA (0.40) USP30FAAHUCHL1
SCHEMBL30774750 0.83 ALDH1A1 (0.48) ALDH1A1KDM4EHPGDCCR3FAAH
SCHEMBL30774400 0.83 CYP3A4 (0.45) ALDH1A1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260092074-A1 Annelated Pyridines as Steroidogenesis Inhibitors, Preparation Method and Use Thereof GUANGZHOU VINNOCENT PHARMACEUTICAL LTD (CN) 2026-04-02 — — US claimed
EP-4574830-A1 ANNELATED PYRIDINE STEROID SYNTHETASE INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF Guangzhou Vinnocent Pharmaceutical Limited (CN) 2025-06-25 — — EP claimed
US-20260092074-A1 Annelated Pyridines as Steroidogenesis Inhibitors, Preparation Method and Use Thereof GUANGZHOU VINNOCENT PHARMACEUTICAL LTD (CN) 2026-04-02 — — US disclosed
EP-4574830-A1 ANNELATED PYRIDINE STEROID SYNTHETASE INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF Guangzhou Vinnocent Pharmaceutical Limited (CN) 2025-06-25 — — EP disclosed
WO-2024061371-A1 ANNELATED PYRIDINE STEROID SYNTHETASE INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF 广州威诺森医药科技有限公司 2024-03-28 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260092074-A1 Annelated Pyridines as Steroidogenesis Inhibitors, Preparation Method and Use Thereof STS, NR5A1, CYP21A2 USP30 728/4885ALDH1A1 610/4885KDM4E 1112/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback